CDKN2A and neoplasm: We next proceeded to determine the patterns of expression for ARF-BP1 and its established partner and target proteins, ARF, p53 and Myc, by qRT-PCR analyses of transcript levels in a large panel of primary B cell lineage neoplasms from NFS.V+ mice diagnosed as SBL, DLBCL of centroblastic (CBL) and immunoblastic (IBL) types, DBLL, and MZL (Figure 1C).